Topics | Percentage |
Biological therapy themes such as primary failure, loss of response, optimization, trough level, anti-drug antibody | 93% |
New drugs in IBD | 74% |
Indications, contraindications and biological therapy monitoring | 72% |
Investigation of chronic diarrhea and IBD differential diagnosis | 64% |
IBD extra intestinal manifestations | 63% |
Management of pregnancy and breastfeeding in IBD patients | 60% |
IBD diagnostic approach such as biomarkers and endoscopic or radiologic exams | 56% |
Conventional treatment of IBD patients | 55% |
CD postoperative follow-up | 54% |
Scientific articles with real-life data | 51% |